Newyork Presbyterian
Mayo Clinic tops list of best US hospitals for diabetes and endocrinology
The Mayo Clinic in Rochester, Minnesota, has repeated as the No. 1 hospital in the U.S. for diabetes and endocrinology, according to the U.S. News & World Report’s 2024-2025 Best Hospitals rankings.
Direct-to-consumer model may improve drug access, but providers warn about possible biases
A new direct-to-consumer health care program launched by Eli Lilly has the potential to improve access to diabetes, obesity and migraine medications in the United States.
SITC issues guideline update about immunotherapy for melanoma
The Society for Immunotherapy of Cancer has issued an update to its melanoma clinical practice guideline.
ACC workbook highlights possibilities, benefits of home-based cardiac care
The idea of a clinician making house calls may seem like a quaint one, but research suggests home-based care could offer advantages to expand capacity, reduce costs and individually tailor treatment in novel ways for cardiology.
Cancer Disparities Progress Report highlights ‘grim reality,’ strides toward equity
In its 2022 Cancer Disparities Progress Report, American Association for Cancer Research discussed advances made in closing substantial gaps in care while underscoring the need for further progress.
COVID-19 more severe in patients with active acute leukemia, myelodysplastic syndrome
Patients with acute leukemia or myelodysplastic syndrome in an active state experienced significantly greater COVID-19 severity but not higher mortality due to the virus, according to research presented at ASH Annual Meeting and Exposition.
Ultrasound renal denervation may be beneficial in hypertension at 6 months
Ultrasound renal denervation in patients with triple-therapy resistant hypertension remained effective at 6 months, according to new data from RADIANCE-HTN TRIO reported at TCT 2021.
Neoadjuvant chemotherapy may be optimal first-line treatment in advanced ovarian cancer
Increased use of neoadjuvant chemotherapy appeared associated with improvements in short-term mortality without sacrificing long-term survival in ovarian cancer, according to a comparative effectiveness research study in JAMA Oncology.
Preoperative pembrolizumab may enhance major pathologic response in esophageal cancer
Adding pembrolizumab to preoperative chemoradiotherapy increased major pathologic response rate compared with historical data among patients with esophageal adenocarcinoma, according to a study presented at the virtual ASCO Annual Meeting.
Barbershop intervention for hypertension may be cost-effective
An intervention for uncontrolled hypertension in the setting of a barbershop may be a cost-effective strategy to improve systolic BP control among Black men, according to data published in Circulation.